Anke Kurreck
Papers
1
Total Citations
6
H-Index
1
About
Anke Kurreck is a researcher whose work sits at the intersection of biochemistry and drug discovery, with a primary focus on nucleoside kinases (NKs)—critical enzymes that activate nucleoside analogues used to treat cancer and viral infections. Her most notable contribution is the development of a semi-automated, high-throughput substrate screening assay for nucleoside kinases, published in 2021. This innovative method enables rapid characterization of NKs, which possess varying specificities, thereby accelerating drug design and the in vitro production of nucleotide analogues. By streamlining the screening process, Kurreck’s work addresses a key bottleneck in the development of more effective and targeted therapies. Although her most cited paper has garnered 6 citations to date, the practical significance of her assay is evident in its potential to transform how researchers evaluate nucleoside analogues, making her a valuable contributor to the fields of enzymology and pharmaceutical biotechnology. Her achievements highlight a commitment to bridging fundamental enzyme research with applied therapeutic development.
Research Focus
Key Achievements
Top Papers
- 1